Ohio Jury Faults Pharmacies for Spurring Opioid Epidemic

November 24, 2021 by Tom Ramstack
Ohio Jury Faults Pharmacies for Spurring Opioid Epidemic

CLEVELAND, Ohio — A landmark jury verdict Tuesday could make major pharmacy chains like CVS, Walgreens and Walmart liable for encouraging the opioid epidemic that kills thousands of Americans each year. 

The verdict in federal court in Ohio is the first to uphold a legal theory underpinning about 3,000 lawsuits nationwide.

Unlike other recent judgments in Oklahoma and California state courts, the U.S. District Court in Cleveland found that the pharmacies created a “public nuisance” by selling a dangerous drug despite its known risks of addiction, overdose and death.

If the decision survives on appeal, it would vastly increase the liability for opioid complications, according to attorneys who handled the case.

The pharmacies “engaged in intentional and/or illegal conduct [that] was a substantial factor in producing the public nuisance,” according to the verdict form. 

A separate court proceeding is scheduled for the spring to determine the penalty for the pharmacies. The plaintiffs are suggesting more than $1 billion for addiction treatment of residents in the two Ohio counties that sued.

“Today’s verdict represents a milestone victory for the Lake County and Trumbull County communities, and the entire country, in the fight against the opioid epidemic,” lawyers for the plaintiffs said in a joint statement.

Lake and Trumbull county officials blamed the pharmacies for making opioids available to consumers in amounts that far exceeded their medical needs. The pharmacies’ business practices “produced a permanent or long-lasting effect upon the public right,” their Aug. 19, 2021 court filing says. 

The trial was the first to hold pharmacies responsible for the opioid epidemic and the first that represented a victory for a local government. Other lawsuits have named opioid distributors and manufacturers as defendants.

The Oklahoma Supreme Court overturned a $465 million judgment this month against pharmaceutical company Johnson & Johnson. In California this month, a judge dismissed a lawsuit against drug manufacturers that make opioids.

All three of the pharmacies said they would appeal. They argued during the trial that they complied with all laws and Food and Drug Administration regulations.

If anyone other than the patients were to be blamed, it was the doctors, they said.

“Prescribers, they have the greatest control over the spigot,” said Brian Swanson, attorney for Walgreens, during closing arguments.

A Walgreens statement said “the trial court committed significant legal errors in allowing the case to go before a jury on a flawed legal theory that is inconsistent with Ohio law.”

A Walmart statement said the trial “was engineered to favor the plaintiffs’ attorneys and was riddled with remarkable legal and factual mistakes.”

CVS officials said they “look forward to the appeals court review of this case, including the misapplication of public nuisance law.”

Tom can be reached at [email protected].

A+
a-
  • CVS
  • pharmacies
  • Walgreens
  • Walmart
  • In The News

    Health

    Voting

    Prescription Drugs

    May 21, 2025
    by Dan McCue
    States, Tribes to Have Easier Time Importing Drugs From Canada

    WASHINGTON — The Food and Drug Administration on Wednesday announced “enhancements” under section 804 of the Federal Food, Drug and... Read More

    WASHINGTON — The Food and Drug Administration on Wednesday announced “enhancements” under section 804 of the Federal Food, Drug and Cosmetic Act to allow states and Indian tribes to more easily import certain prescription drugs from Canada. The move, implementing an executive order signed by President... Read More

    May 12, 2025
    by Dan McCue
    Trump Moves to Lower Prescription Drug Prices

    WASHINGTON — President Donald Trump on Monday announced his intention to try to resurrect a controversial policy from his first... Read More

    WASHINGTON — President Donald Trump on Monday announced his intention to try to resurrect a controversial policy from his first administration in a bid to reduce the cost of some prescription drugs in the United States by linking their prices to those paid abroad. The policy,... Read More

    Pharmaceutical Industry Criticizes Drug Pricing Plan Trump Says He'll Sign

    WASHINGTON (AP) — President Donald Trump's plan to change the pricing model for some medications is already facing fierce criticism from the... Read More

    WASHINGTON (AP) — President Donald Trump's plan to change the pricing model for some medications is already facing fierce criticism from the pharmaceutical industry before he's even signed the executive order set for Monday that, if implemented, could lower the cost of some drugs. Trump has promised that... Read More

    April 18, 2025
    by Dan McCue
    Scores of Generic Medications Recalled Over Quality Issues

    WASHINGTON — Nearly 40 different generic medications have been voluntarily recalled by Glenmark Pharmaceuticals after regulators flagged issues related to... Read More

    WASHINGTON — Nearly 40 different generic medications have been voluntarily recalled by Glenmark Pharmaceuticals after regulators flagged issues related to how the drugs were manufactured in India, the Food and Drug Administration announced Friday. To ensure the safety and uniformity of medicines, the FDA has imposed... Read More

    Pfizer Ends Development of Potential Pill Obesity Treatment

    Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level... Read More

    Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a possible drug-induced liver... Read More

    The Skyrocketing Cost of Weight-Loss Drugs Has State Medicaid Programs Looking for a Solution

    States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to... Read More

    States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by surprise. One solution some policymakers may try is restricting the number of people on Medicaid... Read More

    News From The Well
    scroll top